Compare RVMD & DLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVMD | DLTR |
|---|---|---|
| Founded | 2014 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.1B | 24.4B |
| IPO Year | 2020 | 1996 |
| Metric | RVMD | DLTR |
|---|---|---|
| Price | $208.19 | $130.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 18 |
| Target Price | ★ $140.84 | $123.35 |
| AVG Volume (30 Days) | 1.6M | ★ 2.0M |
| Earning Date | 05-06-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 144.33 |
| EPS | N/A | ★ 1.76 |
| Revenue | N/A | ★ $19,411,800,000.00 |
| Revenue This Year | N/A | $8.48 |
| Revenue Next Year | $533.02 | $5.90 |
| P/E Ratio | ★ N/A | $73.12 |
| Revenue Growth | N/A | ★ 10.43 |
| 52 Week Low | $35.62 | $84.71 |
| 52 Week High | $220.34 | $142.40 |
| Indicator | RVMD | DLTR |
|---|---|---|
| Relative Strength Index (RSI) | 61.88 | 57.95 |
| Support Level | $177.04 | $117.29 |
| Resistance Level | N/A | $132.64 |
| Average True Range (ATR) | 7.36 | 3.25 |
| MACD | 0.46 | -0.30 |
| Stochastic Oscillator | 71.41 | 51.12 |
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Founded in 1986, Dollar Tree operates almost 9,000 small-box discount stores across the United States and Canada, offering roughly 85% of its merchandise under $2. The chain targets value-conscious suburban and urban shoppers with a mix of consumables (49% of sales), variety (45%), and seasonal goods (6%). In fiscal 2025, Dollar Tree generated over $19 billion in sales, through its multi-price strategy, higher-margin discretionary assortments, and private-label products that account for nearly one-third of sales.